Guardant Health, Inc. (GH)

Guardant Health, Inc. (GH) is a healthcare company (diagnostics & research) based in the United States. The share price is $143.34, down 0.48% on the day, which values the company at $19.39B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.

Key facts

Share price
$143.34−0.48% today
Market value
$19.39B
Funk Score
55/100
200-week average
$59.63140% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Guardant Health, Inc. in more detail

GH trades at -505.5× next year's expected earnings, 15.2× sales. It sits 140% above its 200-week average of $59.63.

Over the last five fiscal years Guardant Health, Inc. has compounded revenue 27.9% a year. Its Funk Score is 55 out of 100 (financial strength 4.6, profitability 2.0, growth 10.0, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Share count keeps rising; Thin interest cover.

9 of the superinvestors tracked here hold GH, including Eric Bannasch (7.4% of the portfolio), Karthik Sarma (1.7% of the portfolio), Cathie Wood (0.6% of the portfolio).

Superinvestors holding GH

9 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:GH vs BNTX (Guardant Health, Inc. vs BioNTech)GH vs ALNY (Guardant Health, Inc. vs Alnylam Pharmaceuticals)GH vs ZBH (Guardant Health, Inc. vs Zimmer Biomet Holdings)GH vs THC (Guardant Health, Inc. vs Tenet Healthcare)GH vs VTRS (Guardant Health, Inc. vs Viatris)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Guardant Health, Inc. (GH): questions and answers

What is Guardant Health, Inc.'s market cap?

Guardant Health, Inc. is valued at $19.39B at a share price of $143.34.

Is GH above its 200-week moving average?

Yes. GH is 140.4% above its 200-week average of $59.63. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Guardant Health, Inc. growing?

Over the last five fiscal years Guardant Health, Inc.'s revenue grew 27.9% a year.

Does GH pay a dividend?

Guardant Health, Inc. does not currently pay a regular dividend.

Which famous investors own GH?

In their latest quarterly filings, Eric Bannasch (7.4% of the portfolio), Karthik Sarma (1.7% of the portfolio), Cathie Wood (0.6% of the portfolio), Temasek (0.5% of the portfolio), John Overdeck and David Siegel (founders) (0.4% of the portfolio), Baillie Gifford team (0.3% of the portfolio) hold GH. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Guardant Health, Inc. (GH) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GH

Underlying data: Yahoo Finance; company filings with the SEC.